AMG Pharma Services: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AMG Pharma Services
Largest movements
- Cash -€28,491
down €28,491 (-9.3%), from €305,673 to €277,182
mainly Contributions, distributions and other (-€20,000) and Tax, wage and social debts (-€7,329)
- Reserves -€20,000
down €20,000 (-15.8%), from €126,860 to €106,860
- Tax, wage and social debts -€7,329
no longer reported in 2025 (was €7,329)
- Gross operating margin -€61,742
down €61,742, from €55,276 to -€6,466
- Taxes -€24,833
down €24,833, from €20,333 to -€4,500
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €312,128 | €280,649 | -€31,479 | -10.1% |
| Fixed assets | 21/28 | - | €0 | +€0 | |
| Tangible fixed assets | 22/27 | - | €0 | +€0 | |
| Furniture and vehicles | 24 | - | €0 | +€0 | |
| Current assets | 29/58 | €312,128 | €280,649 | -€31,479 | -10.1% |
| Amounts receivable within one year | 40/41 | €6,455 | €3,468 | -€2,987 | -46.3% |
| Trade receivables | 40 | - | €484 | +€484 | |
| Other amounts receivable | 41 | €6,455 | €2,984 | -€3,471 | -53.8% |
| Cash at bank and in hand | 54/58 | €305,673 | €277,182 | -€28,491 | -9.3% |
| Total equity and liabilities | 10/49 | €312,128 | €280,649 | -€31,479 | -10.1% |
| Equity | 10/15 | €303,476 | €280,649 | -€22,826 | -7.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €126,860 | €106,860 | -€20,000 | -15.8% |
| Non-distributable reserves | 130/1 | €126,860 | €106,860 | -€20,000 | -15.8% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Other | 1319 | €125,000 | €105,000 | -€20,000 | -16.0% |
| Profit (loss) carried forward | 14 | €158,016 | €155,189 | -€2,826 | -1.8% |
| Amounts payable | 17/49 | €8,652 | - | -€8,652 | |
| Amounts payable within one year | 42/48 | €8,652 | - | -€8,652 | |
| Trade debts | 44 | €1,147 | - | -€1,147 | |
| Suppliers | 440/4 | €1,147 | - | -€1,147 | |
| Taxes, remuneration and social security | 45 | €7,329 | - | -€7,329 | |
| Taxes | 450/3 | €7,329 | - | -€7,329 | |
| Other amounts payable | 47/48 | €177 | - | -€177 | |
| Other operating charges | 640/8 | €1,020 | €727 | -€293 | -28.8% |
| Gross operating margin | 9900 | €55,276 | -€6,466 | -€61,742 | |
| Operating profit (loss) | 9901 | €54,256 | -€7,192 | -€61,448 | |
| Financial income | 75/76B | €1 | €64 | +€62 | +5625.2% |
| Recurring financial income | 75 | €1 | €64 | +€62 | +5625.2% |
| Financial charges | 65/66B | €319 | €197 | -€122 | -38.1% |
| Recurring financial charges | 65 | €202 | €197 | -€4 | -2.1% |
| Non-recurring financial charges | 66B | €118 | - | -€118 | |
| Profit (loss) for the period before taxes | 9903 | €53,938 | -€7,326 | -€61,264 | |
| Income taxes | 67/77 | €20,333 | -€4,500 | -€24,833 | |
| Profit (loss) for the period | 9904 | €33,605 | -€2,826 | -€36,431 | |
| Profit (loss) for the period to be appropriated | 9905 | €33,605 | -€2,826 | -€36,431 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.